Published in Genome Med on September 27, 2013
Co-culture of Hepatocytes and Kupffer Cells as an In Vitro Model of Inflammation and Drug-Induced Hepatotoxicity. J Pharm Sci (2016) 0.80
Adaptation to acetaminophen exposure elicits major changes in expression and distribution of the hepatic proteome. Sci Rep (2015) 0.78
Fibri(nogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of MMP12. J Hepatol (2016) 0.77
Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades. Sci Rep (2016) 0.77
Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injury. Genome Med (2013) 0.75
Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury. Int J Mol Sci (2017) 0.75
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38
Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology (2005) 10.66
Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol (2000) 4.58
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49
Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology (2010) 2.26
Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus. Hepatology (2002) 2.06
Sulfide, the first inorganic substrate for human cells. FASEB J (2007) 1.96
Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease. Hepatology (2010) 1.91
Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood (2003) 1.77
Serum proteomic profiling in patients with drug-induced liver injury. Aliment Pharmacol Ther (2012) 1.55
Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc Natl Acad Sci U S A (1995) 1.54
The Japanese toxicogenomics project: application of toxicogenomics. Mol Nutr Food Res (2010) 1.54
Drug-induced liver disease. Clin Liver Dis (2000) 1.46
Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency. N Engl J Med (1996) 1.40
Drug-induced hepatotoxicity: 2005. J Clin Gastroenterol (2005) 1.38
Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death. Nat Genet (1995) 1.27
Role of metabolism in drug-induced idiosyncratic hepatotoxicity. Crit Rev Toxicol (2005) 1.24
Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Hepatology (2007) 1.23
Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs. Pharmacogenet Genomics (2012) 1.21
Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia. Am J Physiol (1991) 1.09
Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin Pharmacol Ther (2010) 1.08
New physiological importance of two classic residual products: carbon monoxide and bilirubin. Biochem Mol Med (1997) 1.07
New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system. Chem Res Toxicol (1999) 1.06
Plasma protein haptoglobin modulates renal iron loading. Am J Pathol (2005) 1.04
Drug hepatotoxicity from a regulatory perspective. Clin Liver Dis (2007) 1.04
Serum adenosine deaminase, 5' nucleotidase and malondialdehyde in acute infective hepatitis. Indian J Clin Biochem (2004) 1.03
Alterations in the rat serum proteome during liver injury from acetaminophen exposure. J Pharmacol Exp Ther (2006) 0.97
A 2-DE MALDI-TOF study to identify disease regulated serum proteins in lung cancer of c-myc transgenic mice. Proteomics (2009) 0.95
Novel mechanism of C-reactive protein for enhancing mouse liver innate immunity. Hepatology (2009) 0.92
Expression of the protective proteins hemopexin and haptoglobin by cells of the neural retina. Exp Eye Res (1998) 0.90
New roles of HDL in inflammation and hematopoiesis. Annu Rev Nutr (2012) 0.90
Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury. Am J Pathol (2012) 0.89
Obesity-associated hepatosteatosis and impairment of glucose homeostasis are attenuated by haptoglobin deficiency. Diabetes (2011) 0.85
Extent of the acute phase response in fulminant hepatic failure. Gut (1994) 0.83
Role of plasminogen in macrophage accumulation during liver repair. Thromb Res (2010) 0.82
Plasminogen is essential for granulation tissue formation during the recovery process after liver injury in mice. J Thromb Haemost (2010) 0.82
Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease. J Clin Pathol (1986) 0.82
Liver disease associated with alpha1-antitrypsin deficiency. Clin Liver Dis (1998) 0.82
Transcriptional and posttranscriptional regulation of apolipoprotein E, A-I, and A-II gene expression in normal rat liver and during several pathophysiologic states. Biochemistry (1990) 0.81
Changes in lipoprotein binding and uptake by hepatocytes during rat liver regeneration. Biosci Rep (1989) 0.81
ApoE genotype-specific inhibition of apoptosis. J Lipid Res (2003) 0.78
Glutathione synthetase-deficient lymphocytes and acetaminophen toxicity. Clin Pharmacol Ther (1981) 0.78
Plasma-kallikrein clearance by the liver of acetaminophen-intoxicated rats. Life Sci (1993) 0.77
Back to basics for idiosyncratic drug-induced liver injury: dose and metabolism make the poison. Gastroenterol Clin Biol (2010) 0.77